Travis Coy

Travis Coy leads business development transaction and M&A execution across Eli Lilly’s therapeutic areas. His leadership, responsibilities and experience range from managing and developing the strategic and economic analyses of transactions (M&A, licensing and equity) to leading negotiations to having had financial leadership of alliances.

He has had a variety of finance and business development experiences at Lilly including positions as Head of Business Development Transactions for Oncology and Diagnostics; Head of Business Development for Cardiometabolic Diseases, Drug Delivery, Device and Connected Solutions; Finance Director of Lilly’s Oncology Business Unit; Director of Investor Relations; Director of Corporate Finance and Investment Banking; and other financial controllership roles.

Before transitioning to finance and business development, he was a Chemist in Lilly’s research laboratories and a Production Manager for Milliken & Company.
Travis earned his MBA from the Ross School of Business at the University of Michigan and his BS in Chemistry from Rose-Hulman Institute of Technology.